SNAP2 and FATHMM-MKL: Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes and Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) disagree
- Low severity
- Not yet reviewed
- two-study-conflict
- unknown
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes ranks FATHMM-MKL above SNAP2 in 3 of 4 comparisons; Livesey and Marsh 2025, Genome Biology 26:104 (Europe PMC full text XML) ranks SNAP2 above FATHMM-MKL in 7 of 7 comparisons. No other study gives a verdict, so neither is the outlier.
2 papers rank SNAP2 above FATHMM-MKL in 8 of their 12 comparisons and FATHMM-MKL higher in 3; 1 is a tie. Of those papers, Clinical likelihood ratios and balanced… ranks FATHMM-MKL higher on its own (3 of 5).
- Compared
- SNAP2, FATHMM-MKL
Not reviewed yet.